MRI scan for diagnosing pancreatic cancer
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study tests if a special MRI scan (MRE) can better diagnose pancreatic masses. It may help doctors find and treat pancreatic cancer more accurately.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a pancreatic mass that was removed by surgery and confirmed to be pancreatic cancer.
- You have not had cancer elsewhere in your body before this diagnosis.
- You did not have a biliary drainage procedure before surgery.
- You are able to have follow-up visits for at least 3 to 6 months after surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether adding an MRI scan improves the selection of people with pancreatic cancer who may benefit from surgery. It focuses on patients without liver spread and with tumors that are borderline or likely removable.
This trial studies using MRI scans to guide radiation therapy for locally advanced pancreas cancer or liver cancer. It may help make radiation planning more precise, either to control the cancer or to ease symptoms.
This trial uses a special MRI scan called 3D MRE to see how well people with pancreatic cancer might do. It looks at the stiffness of the tumor and surrounding tissue to help predict outcomes.
This study tests whether new MRI techniques can better show how pancreatic cancer responds to treatment. It compares standard CT scans with advanced MRI sequences for patients whose cancer has not spread.
This study uses MRI scans to screen for pancreas cancer in people at high risk due to family history or certain gene mutations. It aims to see if MRI can help find cancer early.
This study is testing a new MRI technique that may help predict how well pancreatic cancer treatments will work. You would receive a special substance (called hyperpolarized pyruvate) during a standard MRI scan.
Hear when a new Magnetic Resonance Imaging trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.